IN-DATE
1804325-33: Abbott Xience Skypoint RX Everolimus Eluting Coronary Stent: 3.25mm x 33mm, 145cm
Sign in to add this product to your favorites!
| Price: | $689.00 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 5 box of 1 |
| Expiration: | 08-2028 |
Additional Details
Abbott Xience Skypoint Rapid-Exchange RX Everolimus-Eluting Coronary Stent System
Drug-Eluting Stent
During percutaneous coronary interventions (PCI), small differences between stents can be the determining factor for the patient’s acute and long-term outcomes. XIENCE Skypoint™ Stent has a number of new features that offer broader treatment options to interventional cardiologists (ICs).
Updated features include:
- Larger stent expansion and enhanced stent design
- Slimmer catheter profile with integrated one-piece shaft
- Low crossing forces and excellent pushability
- Improved catheter hub
These new features can help clinicians treat the increasingly wide range of lesions encountered in real-world patients.
AccessGUDID Info
- FDA Product Code: NIQ
- FDA Product Code Name: Coronary drug-eluting stent
- GMDN Term Code: 56284
- GMDN Term Name: Drug-eluting coronary artery stent, non-bioabsorbable-polymer-coated
- GMDN Term Description: A non-bioabsorbable metal tubular mesh structure covered with a non-bioabsorbable polymer and a drug coating that is designed to be implanted, via a delivery catheter, into a coronary artery (or saphenous vein graft) to maintain its patency typically in a patient with symptomatic atherosclerotic heart disease. The drug coating is slowly released and intended to inhibit restenosis by reducing vessel smooth muscle cell proliferation. Disposable devices associated with implantation may be included.
Manufacturer
Abbott’s surgical innovations deliver advanced solutions that enhance precision, safety, and outcomes in the operating room. Building on the legacy of St. Jude Medical, Abbott offers a diverse portfolio of cutting-edge technologies, including structural heart devices like MitraClip™ for mitral valve repair and Amplatzer™ occluders for congenital heart defect closure. Their ProGlide™ vascular closure system and TactiCath™ ablation catheters further demonstrate Abbott’s commitment to empowering surgeons with reliable tools for minimally invasive procedures. By combining innovation with trusted expertise, Abbott continues to shape the future of surgical care. Browse Synergy Surgical's selection of Abbott surgical products, including Balloons, Stents, Vascular Closures and more.
